Skip to main content

CORRECTION article

Front. Immunol. , 27 February 2025

Sec. T Cell Biology

Volume 16 - 2025 | https://doi.org/10.3389/fimmu.2025.1574591

Corrigendum: State of play in the molecular presentation and recognition of anti-tumor lipid-based analogues

  • Infection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia

A Corrigendum on
State of play in the molecular presentation and recognition of anti-tumor lipid-based analogues

By Praveena T and Le Nours J (2024) Front. Immunol. 15:1479382. doi: 10.3389/fimmu.2024.1479382

In the published article, there was an error in Figure 2 as published. In Figure 2B, the annotations for the last two ternary structures (last 2 panels) were inverted, namely, (iNKT TCR-mCD1d-PyrC-α-GalCer - PDB code: 4IRS) and (iNKT TCR-mCD1d-EF77 - PDB code: 4Y4K) were inadvertently swapped. The corrected Figure 2 and its caption appear below.

Figure 2
www.frontiersin.org

Figure 2. Molecular insights into the presentation and recognition of α-GalCer analogues. (A) Cartoon representation of the binding groove of CD1d presenting α-GalCer and modified α-GalCer. The PDB code for each binary complex crystal structure is indicated. The α1/α2 domain forming the hydrophobic binding groove (A′- and F′-pockets) of human CD1d (hCD1d) and mouse CD1d (mCD1d) are shown as cartoon representation in wheat and light blue, respectively. The bound α-GalCer and modified α-GalCer are shown as coloured sticks. Spacer lipids are shown as black sticks. (B) Cartoon representation of the crystal structure of iNKT TCR-CD1d-α-GalCer analogues ternary complexes deposited in the protein databank (PDB). CD1d, grey; TCRα, salmon; TCRβ, light blue; β2-microglobulin (β2m), green. The PDB code of the crystal structures are indicated. (C) Overall superposition of iNKT TCR-CD1d-α-GalCer analogues ternary crystal structures available in the PDB database. (D) Molecular interactions between the iNKT TCR and α-GalCer. Hydrogen bonds are shown as dashed lines. (E) Superposition of the bound O-glycosidic linkage modified α-GalCer. (F) Superposition of the bound acyl and phytosphingosine chains modified α-GalCer. (G) Superposition of the bound 6′′-OH galactose modified α-GalCer. The overall positioning of the CDR1α and CDR3α loops of the iNKT TCR are also shown in (E–G).

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: CD1d, glycolipids, iNKT cells, α-GalCer, tumor, immunotherapy

Citation: Praveena T and Le Nours J (2025) Corrigendum: State of play in the molecular presentation and recognition of anti-tumor lipid-based analogues. Front. Immunol. 16:1574591. doi: 10.3389/fimmu.2025.1574591

Received: 11 February 2025; Accepted: 14 February 2025;
Published: 27 February 2025.

Edited and Reviewed by:

Steven Anthony Porcelli, Albert Einstein College of Medicine, United States

Copyright © 2025 Praveena and Le Nours. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Jérôme Le Nours, amVyb21lLmxlbm91cnNAbW9uYXNoLmVkdQ==

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Research integrity at Frontiers

Man ultramarathon runner in the mountains he trains at sunset

95% of researchers rate our articles as excellent or good

Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


Find out more